第四届监事会第十二次会议决议公告 本公司及监事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 一、监事会召开情况 山东中农联合生物科技股份有限公司（以下简称"公司"）第四届监事会第 十二次会议于 2025 年 8 月 27 日在公司会议室以现场结合通讯方式召开。会议通 知已于 2025 年 8 月 17 日通过邮件及专人送达的方式通知到各位监事。本次会议 应出席监事 3 人，实际出席监事 3 人，会议由监事会主席邓群枝女士主持。会议 召开符合有关法律、法规、规章和《公司章程》的规定，会议合法有效。 二、监事会会议审议情况 会议审议通过了如下议案： 证券代码：003042 证券简称：中农联合 公告编号：2025-027 山东中农联合生物科技股份有限公司 表决结果：1 票赞成，0 票反对，0 票弃权。 （一）审议通过《关于公司 2025 年半年度报告及摘要的议案》 经审核，监事会认为：董事会编制及审核公司 2025 年半年度报告及摘要的 程序符合法律、法规、中国证监会及深圳证券交易所的相关规定，报告真实、准 确、完整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或重 ...

第四届董事会第十四次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 二、董事会会议审议情况 山东中农联合生物科技股份有限公司 一、董事会召开情况 山东中农联合生物科技股份有限公司（以下简称"公司"）第四届董事会第 十四次会议于 2025 年 8 月 27 日在公司会议室以现场结合通讯方式召开。会议通 知已于 2025 年 8 月 17 日通过邮件及专人送达的方式通知到各位董事。本次会议 应出席董事 9 名，实际出席董事 9 名。本次会议由董事长许辉先生主持，监事、 高管列席会议。会议召开符合有关法律、法规和《公司章程》的规定，会议合法 有效。 证券代码：003042 证券简称：中农联合 公告编号：2025-024 （一）审议通过《关于 2025 年半年度报告及其摘要的议案》 （三）审议通过《关于全资子公司与关联方开展融资租赁业务并由公司提 供担保的议案》 同意全资子公司山东省联合农药工业有限公司与供销集团（天津）国际融资 租赁有限公司开展金额不超过 1 亿元的融资租赁金融业务，年利率不超过 3.4%， 期限 3 年，公司为上述融资租赁业务项下的 ...

Core Viewpoint - Zhongnong United (003042.SZ) reported a revenue of 1.064 billion yuan for the first half of 2025, reflecting a year-on-year growth of 7.39% [1] - The company achieved a net profit attributable to shareholders of 3.2097 million yuan, marking a turnaround from a loss to profit [1] - The net profit excluding non-recurring gains and losses was 2.0547 million yuan, with basic earnings per share at 0.02 yuan [1] Financial Performance - Revenue for the first half of 2025 reached 1.064 billion yuan, up 7.39% compared to the same period last year [1] - Net profit attributable to shareholders was 3.2097 million yuan, indicating a recovery from previous losses [1] - The net profit after excluding non-recurring items stood at 2.0547 million yuan, with basic earnings per share reported at 0.02 yuan [1]

Financial Performance - The company's operating revenue for the first half of 2025 reached ¥1,064,178,729.17, representing a 7.39% increase compared to ¥990,987,235.81 in the same period last year[17]. - Net profit attributable to shareholders was ¥3,209,704.14, a significant turnaround from a loss of ¥32,577,717.01 in the previous year, marking a 109.85% improvement[17]. - The basic earnings per share increased to ¥0.02 from a loss of ¥0.23, reflecting an increase of 108.70%[17]. - The total assets of the company at the end of the reporting period were ¥4,088,878,268.25, up 3.94% from ¥3,933,966,777.06 at the end of the previous year[17]. - The net cash flow from operating activities improved by 32.30%, amounting to -¥48,452,218.96, compared to -¥71,567,925.13 in the previous year[17]. - The weighted average return on net assets improved to 0.24% from -2.23% in the previous year, an increase of 2.47%[17]. - The company reported a significant increase in accounts receivable, which rose to ¥512,484,818.21, representing 12.53% of total assets, due to increased sales activity[61]. - The company reported a total profit for the current period of ¥7,475,082.36, compared to a loss of ¥29,278,628.76 in the previous period, indicating a strong recovery[146]. Market and Industry Insights - The global crop protection market is projected to grow from $58.2 billion in 2018 to $74.9 billion by 2023, with an annual growth rate of 5.1%[24]. - In 2024, China's pesticide export volume is expected to reach 2.05 million tons, an increase of nearly 500,000 tons, representing a year-on-year growth of 32%[26]. - The Chinese government emphasizes food security, aiming to stabilize grain production at over 1.3 trillion jin, highlighting the critical role of pesticides in agricultural supply[28]. - The "14th Five-Year Plan" for the pesticide industry aims to enhance domestic supply capacity and international competitiveness, promoting green and sustainable development[30]. - The global population is projected to increase by over 2 billion by the mid-2080s, driving long-term demand for pesticides due to limited arable land[27]. Research and Development - The company has obtained a total of 70 domestic invention patents and 27 utility model patents, with 6 invention patents authorized in 41 countries[35]. - The company is focusing on product innovation, with ongoing registration work for new products such as trifluoromethane and fluoroquinolone esters[40]. - The company has successfully developed and launched the pesticide product Fluopyram, which has independent intellectual property rights, as part of national key research and development plans[45]. Operational Efficiency and Management - The company is enhancing internal controls and cost management to ensure stable production and operational efficiency[38]. - The company emphasizes safety production and environmental protection, achieving stable operations and being recognized as an "advanced (provincial) intelligent factory"[37]. - The company is actively managing foreign exchange risks due to its international market expansion, utilizing financial derivatives to mitigate potential losses[77]. Financial Management and Investments - The company reported a decrease in research and development expenses to ¥33,481,338.12 from ¥38,146,245.41, reflecting a reduction of about 12.5%[146]. - Total investments during the reporting period were ¥124,435,101.84, a decrease of 36.63% from ¥196,374,514.23 in the same period last year[66]. - The company has allocated 309 million yuan for special reserves, which is crucial for future investments and risk management[158]. Corporate Governance and Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares for this period[4]. - The company has no stock incentive plans or employee stock ownership plans in the reporting period[81]. - The company’s independent director, Chen Jie, will resign after serving for six years, and a new independent director, Yang Guangliang, has been elected[124]. Environmental and Social Responsibility - The company has implemented a "Green Agricultural Inputs" action plan to promote environmentally friendly pesticide development[86]. - The company conducted 1,741 agricultural technology training sessions benefiting 190,489 households, covering an area of 3.52 million acres[88]. - The company has received the "2025 China Pesticide Industry Responsibility Care Excellent Practice Unit" award[84].

关于与供销集团财务有限公司关联存贷款的风险持续评估 报告 山东中农联合生物科技股份有限公司（以下简称"公司"）根据中国证券监 督管理委员会和原中国银行保险监督管理委员会《关于规范上市公司与企业集团 财务公司业务往来的通知》（证监发〔2022〕48 号）、《深圳证券交易所上市公司 自律监管指引第 7 号—交易与关联交易》的相关规定，通过查验供销集团财务有 限公司（以下简称"供销财务公司"）《金融许可证》《营业执照》等证件资料， 审阅供销财务公司 2025 年 6 月财务报表（未经审计），对供销财务公司的经营资 质、业务和风险状况进行了持续评估。具体情况报告如下： 一、供销财务公司基本情况 1、基本情况 企业名称：供销集团财务有限公司 成立日期：2014 年 2 月 21 日 企业性质：有限责任公司（法人独资） 注册地址：北京市西城区宣武门外大街甲 1 号 C 座 7 层 法定代表人：熊星明 注册资本：100,000 万元人民币 统一社会信用代码：911100000882799490 金融许可证机构编码：L0191H211000001 2、主要股东：中华全国供销合作总社全资子公司中国供销集团有限公司直 接持有供销 ...

山东中农联合生物科技股份有限公司 法定代表人：许辉 主管会计工作的负责人：李强 会计机构负责人：陈业丽 单位：万元 | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公 | 上市公司核算 | 2025年期初占 | 2025半年度占用累计发 | 2025半年度占用资 | 2025半年度偿还 | 2025半年度期末 | 占用形 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 司的关联关系 | 的会计科目 | 用资金余额 | 生金额（不含利息） | 金的利息（如有） | 累计发生金额 | 占用资金余额 | 成原因 | | | 控股股东、实际控制 | | | | | | | | | | 非经营性占用 | | 人及其附属企业 | | | | | | | | | | | | 小计 | - | - | - | | | | | | | - | | 前控股股东、实际控 | | | | | | | | | | 非经营性占用 | | 制人及其附属企业 | | | | | | | | | | | | 小计 | ...

山东中农联合生物科技股份有限公司 2025 年半年度财务报告全文 2025 年 8 月 山东中农联合生物科技股份有限公司 2025 年半年度财务报告全文 一、财务报告 公司半年度财务报告未经审计。 二、财务报表 1、合并资产负债表 编制单位：山东中农联合生物科技股份有限公司 编制日期：2025 年 06 月 30 日 单位：元 | 项目 | 期末余额 | 期初余额 | | --- | --- | --- | | 流动资产： | | | | 货币资金 | 305,800,087.05 | 425,228,213.20 | | 交易性金融资产 | 50,000,000.00 | | | 应收票据 | | | | 应收账款 | 512,484,818.21 | 314,608,088.67 | | 应收款项融资 | | | | 预付款项 | 12,865,172.33 | 7,802,402.52 | | 其他应收款 | 430,694.62 | 575,639.83 | | 其中：应收利息 | | | | 应收股利 | | | | 存货 | 517,834,039.40 | 502,126,638.30 | | ...

证券代码：003042 证券简称：中农联合 公告编号：2025-028 5、本次公司为山东联合提供担保属于公司年度担保额度范围内的事项，已经公 山东中农联合生物科技股份有限公司 关于全资子公司开展融资租赁业务暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东中农联合生物科技股份有限公司（以下简称"公司"）于2025年8月27日召 开了第四届董事会第十四次会议及第四届监事会第十二次会议，会议审议通过了《关 于全资子公司与关联方开展融资租赁业务并由公司提供担保的议案》，公司董事会及 监事会审议上述议案时，关联董事丁璐、柳金宏、韩岩及关联监事邓群枝、贾密源 回避表决。该议案尚需提交公司2025年第一次临时股东大会审议。具体情况如下： 一、关联交易概述 1、公司全资子公司山东省联合农药工业有限公司（以下简称"山东联合"）拟 与供销集团（天津）国际融资租赁有限公司(以下简称"供销融资租赁公司")以售 后回租方式开展融资租赁业务，融资金额不超过人民币1亿元，年利率不超过3.4%， 期限3年，公司为上述融资租赁业务项下的债权提供连带责任保证担保，融资额度 ...

Group 1 - The company, Shandong Zhongnong United Biotechnology Co., Ltd., will hold a semi-annual performance briefing on September 1, 2025, from 15:00 to 16:00 [1][3] - The briefing will be conducted online via the "Value Online" platform, allowing for interactive communication with investors [1][3] - The company aims to provide comprehensive insights into its operational performance and development strategies during the briefing [1] Group 2 - The semi-annual report and summary will be disclosed on August 29, 2025, on the Giant Tide Information Network [1] - Investors can submit questions prior to the briefing, and the company will address commonly asked questions during the session [1]

Group 1 - The core viewpoint of the article highlights the continuous increase in glyphosate raw material prices since May, with a reported price of 27,500 yuan/ton for 95% purity and 28,000 yuan/ton for 97% purity, reflecting a 20% increase since early May [1] - Supply and demand analysis indicates that glyphosate weekly production reached 8,600 tons as of August 24, an 18.71% increase from the previous week, while inventory decreased to 27,800 tons, indicating a tight supply situation that supports price stability [1] - A total of 11 A-share companies are involved in glyphosate, with an average stock price increase of 2.42% on August 26, led by Jiangshan Chemical, Runfeng Co., and Xingfa Group with gains of 5.7%, 3.94%, and 3.85% respectively [1] Group 2 - Performance data from the semi-annual reports show that Zhongnong United turned a profit, while Ando麦 A reduced losses, and companies like Runfeng Co., Jiangshan Chemical, Guoguang Co., and Yangnong Chemical reported year-on-year profit growth [1] - The stock performance of glyphosate-related companies on August 26 shows significant variations in net profit growth, with Jiangshan Chemical at 98.18%, Runfeng Co. at 205.62%, and Xingfa Group at -9.72% [3]